Oil & Gas Exploration & Production
Compare Stocks
5 / 10Stock Comparison
BRN vs REX vs GPRE vs TPVG vs ANDE
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Asset Management
Food Distribution
BRN vs REX vs GPRE vs TPVG vs ANDE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Chemicals - Specialty | Chemicals - Specialty | Asset Management | Food Distribution |
| Market Cap | $14M | $1.64B | $1.27B | $234M | $2.43B |
| Revenue (TTM) | $12M | $651M | $1.94B | $97M | $10.98B |
| Net Income (TTM) | $-7M | $50M | $-15M | $-12M | $129M |
| Gross Margin | 8.6% | 12.7% | 1.8% | 83.5% | 6.6% |
| Operating Margin | -50.9% | 8.6% | 1.2% | 77.9% | 1.1% |
| Forward P/E | — | 64.1x | 29.5x | 6.2x | 13.5x |
| Total Debt | $264K | $21M | $508M | $469M | $1.04B |
| Cash & Equiv. | $3M | $196M | $182M | $20M | $98M |
BRN vs REX vs GPRE vs TPVG vs ANDE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Barnwell Industries… (BRN) | 100 | 189.7 | +89.7% |
| REX American Resour… (REX) | 100 | 508.5 | +408.5% |
| Green Plains Inc. (GPRE) | 100 | 212.7 | +112.7% |
| TriplePoint Venture… (TPVG) | 100 | 57.6 | -42.4% |
| The Andersons, Inc. (ANDE) | 100 | 551.3 | +451.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRN vs REX vs GPRE vs TPVG vs ANDE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRN lags the leaders in this set but could rank higher in a more targeted comparison.
REX is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 476.3% 10Y total return vs ANDE's 194.5%
- Lower volatility, beta 0.28, Low D/E 3.3%, current ratio 8.64x
- Beta 0.28, current ratio 8.64x
- Beta 0.28 vs GPRE's 1.15, lower leverage
GPRE ranks third and is worth considering specifically for momentum.
- +373.7% vs BRN's -16.7%
TPVG carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 36.6%, EPS growth 48.8%
- 36.6% NII/revenue growth vs BRN's -36.9%
- Lower P/E (6.2x vs 29.5x)
- 50.6% margin vs BRN's -53.1%
ANDE is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 23 yrs, beta 0.36, yield 1.1%
- PEG 0.21 vs TPVG's 6.14
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.6% NII/revenue growth vs BRN's -36.9% | |
| Value | Lower P/E (6.2x vs 29.5x) | |
| Quality / Margins | 50.6% margin vs BRN's -53.1% | |
| Stability / Safety | Beta 0.28 vs GPRE's 1.15, lower leverage | |
| Dividends | 17.8% yield, vs ANDE's 1.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +373.7% vs BRN's -16.7% | |
| Efficiency (ROA) | 6.7% ROA vs BRN's -30.7%, ROIC 11.4% vs -61.9% |
BRN vs REX vs GPRE vs TPVG vs ANDE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BRN vs REX vs GPRE vs TPVG vs ANDE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TPVG leads in 2 of 6 categories
REX leads 2 • BRN leads 0 • GPRE leads 0 • ANDE leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TPVG leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ANDE is the larger business by revenue, generating $11.0B annually — 882.5x BRN's $12M. TPVG is the more profitable business, keeping 50.6% of every revenue dollar as net income compared to BRN's -53.1%. On growth, REX holds the edge at +0.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $12M | $651M | $1.9B | $97M | $11.0B |
| EBITDAEarnings before interest/tax | -$3M | $67M | $122M | -$22M | $218M |
| Net IncomeAfter-tax profit | -$7M | $50M | -$15M | -$12M | $129M |
| Free Cash FlowCash after capex | -$607,000 | $18M | $90M | -$59M | -$105M |
| Gross MarginGross profit ÷ Revenue | +8.6% | +12.7% | +1.8% | +83.5% | +6.6% |
| Operating MarginEBIT ÷ Revenue | -50.9% | +8.6% | +1.2% | +77.9% | +1.1% |
| Net MarginNet income ÷ Revenue | -53.1% | +7.7% | -0.8% | +50.6% | +1.2% |
| FCF MarginFCF ÷ Revenue | -4.9% | +2.7% | +4.7% | -58.7% | -1.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -40.2% | +0.4% | -25.9% | — | -1.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +31.6% | +2.9% | +134.2% | -2.3% | +96.0% |
Valuation Metrics
TPVG leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 4.7x trailing earnings, TPVG trades at a 84% valuation discount to REX's 30.1x P/E. Adjusting for growth (PEG ratio), ANDE offers better value at 0.39x vs TPVG's 4.67x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $14M | $1.6B | $1.3B | $234M | $2.4B |
| Enterprise ValueMkt cap + debt − cash | $11M | $1.5B | $1.6B | $683M | $3.4B |
| Trailing P/EPrice ÷ TTM EPS | -1.59x | 30.11x | -10.11x | 4.73x | 25.52x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 64.10x | 29.48x | 6.23x | 13.52x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.57x | — | 4.67x | 0.39x |
| EV / EBITDAEnterprise value multiple | — | 16.98x | 112.32x | 9.02x | 12.91x |
| Price / SalesMarket cap ÷ Revenue | 1.01x | 2.55x | 0.61x | 2.41x | 0.22x |
| Price / BookPrice ÷ Book value/share | 1.58x | 2.72x | 1.59x | 0.66x | 1.89x |
| Price / FCFMarket cap ÷ FCF | — | — | 19.71x | — | — |
Profitability & Efficiency
REX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ANDE delivers a 9.5% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-81 for BRN. REX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to TPVG's 1.33x. On the Piotroski fundamental quality scale (0–9), ANDE scores 6/9 vs BRN's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -80.6% | +7.7% | -2.0% | -3.4% | +9.5% |
| ROA (TTM)Return on assets | -30.7% | +6.7% | -1.0% | -1.5% | +3.6% |
| ROICReturn on invested capital | -61.9% | +11.4% | -5.2% | +7.2% | +4.6% |
| ROCEReturn on capital employed | -27.5% | +10.1% | -6.2% | +9.4% | +5.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 4 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.04x | 0.03x | 0.66x | 1.33x | 0.81x |
| Net DebtTotal debt minus cash | -$3M | -$175M | $326M | $449M | $945M |
| Cash & Equiv.Liquid assets | $3M | $196M | $182M | $20M | $98M |
| Total DebtShort + long-term debt | $264,000 | $21M | $508M | $469M | $1.0B |
| Interest CoverageEBIT ÷ Interest expense | -991.14x | — | -0.08x | -1.02x | 3.21x |
Total Returns (Dividends Reinvested)
REX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REX five years ago would be worth $38,995 today (with dividends reinvested), compared to $4,242 for BRN. Over the past 12 months, GPRE leads with a +373.7% total return vs BRN's -16.7%. The 3-year compound annual growth rate (CAGR) favors REX at 51.8% vs BRN's -25.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.3% | +53.3% | +76.9% | -9.6% | +35.4% |
| 1-Year ReturnPast 12 months | -16.7% | +145.3% | +373.7% | +7.4% | +109.9% |
| 3-Year ReturnCumulative with dividends | -58.3% | +250.1% | -41.2% | -5.6% | +98.7% |
| 5-Year ReturnCumulative with dividends | -57.6% | +290.0% | -39.3% | -15.2% | +139.5% |
| 10-Year ReturnCumulative with dividends | -27.9% | +476.3% | +32.9% | +91.2% | +194.5% |
| CAGR (3Y)Annualised 3-year return | -25.3% | +51.8% | -16.2% | -1.9% | +25.7% |
Risk & Volatility
Evenly matched — BRN and GPRE each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRN is the less volatile stock with a -0.34 beta — it tends to amplify market swings less than GPRE's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GPRE currently trades 96.0% from its 52-week high vs BRN's 48.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.34x | 0.28x | 1.15x | 0.77x | 0.36x |
| 52-Week HighHighest price in past year | $2.28 | $53.36 | $18.94 | $7.53 | $82.11 |
| 52-Week LowLowest price in past year | $0.93 | $19.44 | $3.39 | $4.48 | $31.53 |
| % of 52W HighCurrent price vs 52-week peak | +48.2% | +93.1% | +96.0% | +76.6% | +87.0% |
| RSI (14)Momentum oscillator 0–100 | 48.5 | 61.3 | 49.9 | 67.6 | 42.3 |
| Avg Volume (50D)Average daily shares traded | 927K | 204K | 1.5M | 501K | 335K |
Analyst Outlook
Evenly matched — TPVG and ANDE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: REX as "Buy", GPRE as "Buy", TPVG as "Hold", ANDE as "Buy". Consensus price targets imply 55.1% upside for TPVG (target: $9) vs -9.3% for GPRE (target: $17). For income investors, TPVG offers the higher dividend yield at 17.76% vs ANDE's 1.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $60.00 | $16.50 | $8.95 | $75.00 |
| # AnalystsCovering analysts | — | 3 | 20 | 12 | 21 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +17.8% | +1.1% |
| Dividend StreakConsecutive years of raises | 2 | — | 0 | 0 | 23 |
| Dividend / ShareAnnual DPS | — | — | — | $1.02 | $0.79 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.9% | +2.4% | 0.0% | +0.6% |
TPVG leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). REX leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
BRN vs REX vs GPRE vs TPVG vs ANDE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRN or REX or GPRE or TPVG or ANDE a better buy right now?
For growth investors, TriplePoint Venture Growth BDC Corp.
(TPVG) is the stronger pick with 36. 6% revenue growth year-over-year, versus -36. 9% for Barnwell Industries, Inc. (BRN). TriplePoint Venture Growth BDC Corp. (TPVG) offers the better valuation at 4. 7x trailing P/E (6. 2x forward), making it the more compelling value choice. Analysts rate REX American Resources Corporation (REX) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRN or REX or GPRE or TPVG or ANDE?
On trailing P/E, TriplePoint Venture Growth BDC Corp.
(TPVG) is the cheapest at 4. 7x versus REX American Resources Corporation at 30. 1x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Andersons, Inc. wins at 0. 21x versus TriplePoint Venture Growth BDC Corp. 's 6. 14x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BRN or REX or GPRE or TPVG or ANDE?
Over the past 5 years, REX American Resources Corporation (REX) delivered a total return of +290.
0%, compared to -57. 6% for Barnwell Industries, Inc. (BRN). Over 10 years, the gap is even starker: REX returned +476. 3% versus BRN's -27. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRN or REX or GPRE or TPVG or ANDE?
By beta (market sensitivity over 5 years), Barnwell Industries, Inc.
(BRN) is the lower-risk stock at -0. 34β versus Green Plains Inc. 's 1. 15β — meaning GPRE is approximately -434% more volatile than BRN relative to the S&P 500. On balance sheet safety, REX American Resources Corporation (REX) carries a lower debt/equity ratio of 3% versus 133% for TriplePoint Venture Growth BDC Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — BRN or REX or GPRE or TPVG or ANDE?
By revenue growth (latest reported year), TriplePoint Venture Growth BDC Corp.
(TPVG) is pulling ahead at 36. 6% versus -36. 9% for Barnwell Industries, Inc. (BRN). On earnings-per-share growth, the picture is similar: TriplePoint Venture Growth BDC Corp. grew EPS 48. 8% year-over-year, compared to -39. 5% for Green Plains Inc.. Over a 3-year CAGR, REX leads at -6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRN or REX or GPRE or TPVG or ANDE?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus -50. 4% for Barnwell Industries, Inc. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -39. 1% for BRN. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRN or REX or GPRE or TPVG or ANDE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Andersons, Inc. (ANDE) is the more undervalued stock at a PEG of 0. 21x versus TriplePoint Venture Growth BDC Corp. 's 6. 14x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 2x forward P/E versus 64. 1x for REX American Resources Corporation — 57. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 55. 1% to $8. 95.
08Which pays a better dividend — BRN or REX or GPRE or TPVG or ANDE?
In this comparison, TPVG (17.
8% yield), ANDE (1. 1% yield) pay a dividend. BRN, REX, GPRE do not pay a meaningful dividend and should not be held primarily for income.
09Is BRN or REX or GPRE or TPVG or ANDE better for a retirement portfolio?
For long-horizon retirement investors, The Andersons, Inc.
(ANDE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 36), 1. 1% yield, +194. 5% 10Y return). Both have compounded well over 10 years (ANDE: +194. 5%, GPRE: +32. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRN and REX and GPRE and TPVG and ANDE?
These companies operate in different sectors (BRN (Energy) and REX (Basic Materials) and GPRE (Basic Materials) and TPVG (Financial Services) and ANDE (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BRN is a small-cap quality compounder stock; REX is a small-cap quality compounder stock; GPRE is a small-cap quality compounder stock; TPVG is a small-cap high-growth stock; ANDE is a small-cap quality compounder stock. TPVG, ANDE pay a dividend while BRN, REX, GPRE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.